Canara HSBC (CANHLIFE)
Fast GrowerFairStock Score: 20/100 — RISKY
Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹148.71 |
| Market Cap | ₹14,090.05 Cr |
| P/E Ratio | 107.76 |
| ROCE | 8.73% |
| ROE | 8.28% |
| Dividend Yield | 0.27% |
| Profit Growth | 21.7% |
| Debt/Equity | 0.15 |
| Sales Growth | 20.4% |
| Promoter Holding | 62% |
| 52-Week Range | ₹106 — ₹166.5 |
| Sector | Insurance |
| Book Value | ₹17.42 |
Strengths
- Sales growth of 177.11% shows strong market momentum and business-writing ability.
- Latest quarter revenue of ₹4,202 Cr demonstrates meaningful scale in the life insurance franchise.
- Promoter holding of 62% keeps controlling shareholders and minority investors broadly aligned.
- Stock is 12% below its 52-week high, not at a euphoric peak, though still richly valued.
Concerns
- P/E of 118.16 and P/B of 8.89 against book value of ₹16.47 leave an extremely thin margin of safety.
- ROE of 8.11% is mediocre for a business trading at nearly 9 times book.
- Sales grew 177% but profit fell 5.70%; latest quarter net profit of ₹28 Cr on ₹4,202 Cr sales is roughly 0.7% margin.
- Piotroski F-score of 4/9 and FairStock Score of 25/100 point to poor financial strength; no dividend adds no compensation for waiting.
AI Analysis
At ₹146.45, Mr. Market is asking me to pay 118 times earnings and 8.89 times book value for Canara HSBC. Graham would call that margin of safety? No. The company grew sales 177%, but profits fell 5.70%—and the latest quarter’s ₹28 Cr profit on ₹4,202 Cr revenue is a net margin near 0.7%. That is top-line hope, not bottom-line proof. ROE of 8.11% is unexciting, especially after paying nearly nine times book for an insurer earning returns below my required rate. The Piotroski F-score of 4/9 reinforces my unease: low score means weak internal signals, not a fortress. I cannot calculate a traditional debt/equity for a life insurer, so I rely on earnings quality and margins; both are thin. Promoter holding at 62% does align interests, and the 52-week range shows the stock is not at an extreme high, but the valuation still leaves no room for error. The PEG of 0.67 looks seductive, but it is built on a 177% sales growth figure that is not translating into shareholder profits; Graham preferred profit growth with demonstrable earnings, not merely premium inflows. With no dividend, the investor gets no compensation while waiting. In my circle, I want predictable earnings power and a fair price. Here I see market enthusiasm pricing perfection into a business earning mediocre ROE. If the profit can catch up with the growth, the story changes; until then, this is a high-risk growth story, not a value investment.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer